Another clinical trial that investigated the effect of 6 months CR in patients with type 2 diabetes with abdominal obesity, showed that the CR improved glomerular hyperfiltration, decreased cardiovascular risk factors and improved insulin sensitivity [93]. The gene discussed is INS; the disease is type 2 diabetes mellitus.